Latest filing published 02 Mar 2023 for Abbott Laboratories, €511k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joseph J. Manning: trading record in brief
This profile gathers the share dealings of Joseph J. Manning in Abbott Laboratories, where the filings describe the role as senior executive. Over a trading history stretching from 3 February 2017 to 1 March 2023, the count stands at 50 filings.
No open-market purchase appears, only 25 sales worth €15.2M. Other entries cover 18 share grants and 7 option exercises. Since January 2023: no purchases and 1 sale on the market.
The record was last updated on 2 March 2023 with an open-market sale (€127k) in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph J. Manning
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,438 shares@ US$99.7716.0% of flowCommon shares without par valueSEC:0001415889-23-003910:0
- 15,855 shares0Common shares without par valueSEC:0001415889-23-003055:0
- 23,008 shares@ US$44.4031.9% of flowCommon shares without par valueSEC:0001415889-22-009508:0
- 23,008 shares@ US$44.4032.0% of flowCommon shares without par valueSEC:0001415889-22-009123:0
- 5,850 shares@ US$122.4120.0% of flowCommon shares without par valueSEC:0001415889-22-002196:0
- 15,523 shares0Common shares without par valueSEC:0001415889-22-001740:0
6 of 6 declarations
